$6.07
-0.07-1.14%
In chiusura: -
$6.07
N/A
After hour: 4:00 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Nuvectis Pharma Inc (NASDAQ:NVCT) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 987.67K a 900.78K. Questo rappresenta il 5.86% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 68.22K azioni scambiate al giorno, ci vorrebbero 13.2 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
900.78K
Vendite allo scoperto %
5.86%
Giorni di copertura
13.2
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
NVCT | Nuvectis Pharma, Inc. Common S | 10/15/2025 | 10/24/2025 | 5.86% | 15,368,770 | 900,775 | 68,221 | 13.2 | |
NVCT | Nuvectis Pharma, Inc. Common S | 09/30/2025 | 10/09/2025 | 6.43% | 15,368,770 | 987,672 | 106,425 | 9.28 | |
NVCT | Nuvectis Pharma, Inc. Common S | 09/15/2025 | 09/24/2025 | 5.56% | 15,368,770 | 854,558 | 73,467 | 11.63 | |
NVCT | Nuvectis Pharma, Inc. Common S | 08/29/2025 | 09/10/2025 | 6.40% | 15,368,770 | 982,835 | 57,570 | 17.07 | |
NVCT | Nuvectis Pharma, Inc. Common S | 08/15/2025 | 08/26/2025 | 6.61% | 15,368,770 | 1,015,746 | 151,061 | 6.72 | |
NVCT | Nuvectis Pharma, Inc. Common S | 07/31/2025 | 08/11/2025 | 6.93% | 15,368,770 | 1,064,421 | 266,727 | 3.99 | |
NVCT | Nuvectis Pharma, Inc. Common S | 07/15/2025 | 07/24/2025 | 24.47% | 10,805,429 | 2,644,379 | 87,350 | 30.27 | |
NVCT | Nuvectis Pharma, Inc. Common S | 06/30/2025 | 07/10/2025 | 24.44% | 10,805,429 | 2,640,426 | 280,877 | 9.4 | |
NVCT | Nuvectis Pharma, Inc. Common S | 06/13/2025 | 06/25/2025 | 19.64% | 10,805,429 | 2,122,693 | 97,866 | 21.69 | |
NVCT | Nuvectis Pharma, Inc. Common S | 05/30/2025 | 06/10/2025 | 19.52% | 10,805,429 | 2,109,698 | 118,748 | 17.77 | |
NVCT | Nuvectis Pharma, Inc. Common S | 05/15/2025 | 05/27/2025 | 19.46% | 10,805,429 | 2,102,399 | 136,918 | 15.36 | |
NVCT | Nuvectis Pharma, Inc. Common S | 04/30/2025 | 05/09/2025 | 13.28% | 14,224,340 | 1,888,846 | 186,678 | 10.12 | |
NVCT | Nuvectis Pharma, Inc. Common S | 04/15/2025 | 04/25/2025 | 11.48% | 14,224,340 | 1,632,838 | 108,378 | 15.07 | |
NVCT | Nuvectis Pharma, Inc. Common S | 03/31/2025 | 04/09/2025 | 11.44% | 14,224,340 | 1,627,920 | 157,069 | 10.36 | |
NVCT | Nuvectis Pharma, Inc. Common S | 03/14/2025 | 03/25/2025 | 10.47% | 14,224,340 | 1,489,076 | 91,963 | 16.19 | |
NVCT | Nuvectis Pharma, Inc. Common S | 02/28/2025 | 03/11/2025 | 9.44% | 14,224,340 | 1,342,116 | 82,304 | 16.31 | |
NVCT | Nuvectis Pharma, Inc. Common S | 02/14/2025 | 02/26/2025 | 11.75% | 13,258,814 | 1,557,551 | 175,555 | 8.87 | |
NVCT | Nuvectis Pharma, Inc. Common S | 01/31/2025 | 02/11/2025 | 14.60% | 10,153,814 | 1,482,776 | 77,072 | 19.24 | |
NVCT | Nuvectis Pharma, Inc. Common S | 01/15/2025 | 01/27/2025 | 14.55% | 10,153,814 | 1,477,329 | 120,124 | 12.3 | |
NVCT | Nuvectis Pharma, Inc. Common S | 12/31/2024 | 01/10/2025 | 13.98% | 10,153,814 | 1,418,996 | 110,095 | 12.89 | |
NVCT | Nuvectis Pharma, Inc. Common S | 12/13/2024 | 12/24/2024 | 14.23% | 10,153,814 | 1,444,440 | 76,654 | 18.84 | |
NVCT | Nuvectis Pharma, Inc. Common S | 11/29/2024 | 12/10/2024 | 13.99% | 10,153,814 | 1,420,289 | 139,926 | 10.15 | |
NVCT | Nuvectis Pharma, Inc. Common S | 11/15/2024 | 11/26/2024 | 13.74% | 10,153,814 | 1,394,796 | 414,687 | 3.36 | |
NVCT | Nuvectis Pharma, Inc. Common S | 10/31/2024 | 11/11/2024 | 11.13% | 10,153,814 | 1,130,105 | 201,839 | 5.6 | |
NVCT | Nuvectis Pharma, Inc. Common S | 10/15/2024 | 10/24/2024 | 11.04% | 9,485,529 | 1,046,818 | 78,830 | 13.28 | |
NVCT | Nuvectis Pharma, Inc. Common S | 09/30/2024 | 10/09/2024 | 10.43% | 9,485,529 | 989,582 | 100,639 | 9.83 | |
NVCT | Nuvectis Pharma, Inc. Common S | 09/13/2024 | 09/24/2024 | 10.30% | 9,485,529 | 977,049 | 74,211 | 13.17 | |
NVCT | Nuvectis Pharma, Inc. Common S | 08/30/2024 | 09/11/2024 | 9.75% | 9,485,529 | 924,379 | 152,975 | 6.04 | |
NVCT | Nuvectis Pharma, Inc. Common S | 07/31/2024 | 08/09/2024 | 8.87% | 9,485,529 | 841,234 | 36,355 | 23.14 | |
NVCT | Nuvectis Pharma, Inc. Common S | 07/15/2024 | 07/24/2024 | 9.62% | 9,188,901 | 884,188 | 65,641 | 13.47 | |
NVCT | Nuvectis Pharma, Inc. Common S | 06/28/2024 | 07/10/2024 | 11.71% | 9,188,901 | 1,076,357 | 200,532 | 5.37 | |
NVCT | Nuvectis Pharma, Inc. Common S | 06/14/2024 | 06/26/2024 | 12.50% | 9,188,901 | 1,148,929 | 60,945 | 18.85 | |
NVCT | Nuvectis Pharma, Inc. Common S | 05/31/2024 | 06/11/2024 | 12.69% | 9,188,901 | 1,165,687 | 97,662 | 11.94 | |
NVCT | Nuvectis Pharma, Inc. Common S | 05/15/2024 | 05/24/2024 | 11.13% | 9,188,901 | 1,022,939 | 109,189 | 9.37 | |
NVCT | Nuvectis Pharma, Inc. Common S | 04/30/2024 | 05/09/2024 | 10.27% | 9,188,901 | 943,965 | 69,136 | 13.65 | |
NVCT | Nuvectis Pharma, Inc. Common S | 04/15/2024 | 04/24/2024 | 8.94% | 9,203,599 | 822,550 | 61,025 | 13.48 | |
NVCT | Nuvectis Pharma, Inc. Common S | 03/28/2024 | 04/09/2024 | 8.77% | 9,213,175 | 808,232 | 105,195 | 7.68 | |
NVCT | Nuvectis Pharma, Inc. Common S | 03/15/2024 | 03/26/2024 | 8.32% | 9,213,175 | 766,094 | 127,762 | 6 | |
NVCT | Nuvectis Pharma, Inc. Common S | 02/29/2024 | 03/11/2024 | 7.85% | 9,213,175 | 723,623 | 158,243 | 4.57 | |
NVCT | Nuvectis Pharma, Inc. Common S | 02/15/2024 | 02/27/2024 | 6.87% | 8,770,945 | 602,187 | 62,386 | 9.65 | |
NVCT | Nuvectis Pharma, Inc. Common S | 01/31/2024 | 02/09/2024 | 5.74% | 8,770,945 | 503,414 | 120,399 | 4.18 | |
NVCT | Nuvectis Pharma, Inc. Common S | 01/12/2024 | 01/24/2024 | 4.57% | 8,770,945 | 400,569 | 71,781 | 5.58 | |
NVCT | Nuvectis Pharma, Inc. Common S | 12/29/2023 | 01/10/2024 | 4.13% | 8,770,945 | 362,656 | 73,495 | 4.93 | |
NVCT | Nuvectis Pharma, Inc. Common S | 12/15/2023 | 12/27/2023 | 3.86% | 8,770,945 | 338,782 | 44,621 | 7.59 | |
NVCT | Nuvectis Pharma, Inc. Common S | 11/30/2023 | 12/11/2023 | 3.97% | 8,770,945 | 348,423 | 23,942 | 14.55 | |
NVCT | Nuvectis Pharma, Inc. Common S | 11/15/2023 | 11/27/2023 | 3.94% | 8,770,945 | 345,549 | 42,892 | 8.06 |
In cerca di azioni più vendute allo scoperto?